| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/JSO.23158 |
| P698 | PubMed publication ID | 22648960 |
| P2093 | author name string | Zhi-Wei Zhou | |
| Shi Chen | |||
| Yuan-Fang Li | |||
| Ying-Bo Chen | |||
| Xiu-Hong Yuan | |||
| Xing-Yu Feng | |||
| P2860 | cites work | Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial | Q27851578 |
| Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction | Q28215716 | ||
| Cancer statistics, 2007 | Q29547293 | ||
| Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer | Q33488159 | ||
| Epidemiology of gastric cancer | Q33788193 | ||
| Solitary colorectal liver metastasis: resection determines outcome | Q34567525 | ||
| Technology of hyperthermic intraperitoneal chemotherapy in the United States, Europe, China, Japan, and Korea | Q34609336 | ||
| Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group | Q36619190 | ||
| Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer | Q36706401 | ||
| Hepatic resection for the treatment of liver metastases in gastric carcinoma: review of the literature | Q37107276 | ||
| Adjuvant and neoadjuvant therapy of gastric cancer: a comparison of three pivotal studies | Q37258937 | ||
| Long-term results of cytoreduction and HIPEC followed by systemic chemotherapy | Q37531794 | ||
| Role of the CXCL12/CXCR4 axis in peritoneal carcinomatosis of gastric cancer | Q40314315 | ||
| Risk factors for complications following resection of large gastric cancer | Q43600100 | ||
| Multi-institutional trial of preoperative chemoradiotherapy in patients with potentially resectable gastric carcinoma | Q44978576 | ||
| Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases | Q46238919 | ||
| Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. | Q53604465 | ||
| Achieving R0 resection for locally advanced gastric cancer: is it worth the risk of multiorgan resection?1 1No competing interests declared | Q57846714 | ||
| P433 | issue | 7 | |
| P921 | main subject | patient | Q181600 |
| gastrectomy | Q827390 | ||
| P304 | page(s) | 862-871 | |
| P577 | publication date | 2012-05-30 | |
| P1433 | published in | Journal of Surgical Oncology | Q1919535 |
| P1476 | title | Significance of palliative gastrectomy for late-stage gastric cancer patients | |
| P478 | volume | 106 |
| Q58804570 | A nomogram to predict prognosis for gastric cancer with peritoneal dissemination |
| Q38723809 | Addition of peritonectomy to gastrectomy can predict good prognosis of gastric adenocarcinoma patients with intraoperatively proven single P1/P2 carcinomatosis |
| Q37661578 | Body mass index (BMI) may be a prognostic factor for gastric cancer with peritoneal dissemination |
| Q26765314 | Clinical modalities for management of gastric cancer hepatic metastasis |
| Q27496690 | Clinical significance of palliative gastrectomy on the survival of patients with incurable advanced gastric cancer: a systematic review and meta-analysis |
| Q90202864 | Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China |
| Q89312944 | Distant nodal metastasis: is it always an unresectable disease? |
| Q52655174 | Glasgow Prognostic Score is superior to ECOG PS as a prognostic factor in patients with gastric cancer with peritoneal seeding. |
| Q28080545 | Hepatic metastases from gastric cancer: A surgical perspective |
| Q90434141 | Is there a role for treatment-oriented surgery in stage IV gastric cancer? A systematic review |
| Q38527676 | Metastatic gastric cancer (MGC) patients: Can we improve survival by metastasectomy? A systematic review and meta-analysis |
| Q37226138 | Network pharmacology dissection of multiscale mechanisms of herbal medicines in stage IV gastric adenocarcinoma treatment |
| Q53287195 | Noncurative Resection for Gastric Cancer Patients: Who Could Benefit? : Determining Prognostic Factors for Patient Selection. |
| Q43508289 | Noncurative gastrectomy for gastric adenocarcinoma should only be performed in highly selected patients |
| Q36306641 | Palliative gastrectomy is beneficial in selected cases of metastatic gastric cancer |
| Q59126259 | Palliative gastrectomy plus chemotherapy versus chemotherapy alone for incurable advanced gastric cancer: a meta-analysis |
| Q41718964 | Prognostic factors in patients with loco-regionally advanced gastric cancer |
| Q37592214 | Prognostic nutritional index is an independent prognostic factor for gastric cancer patients with peritoneal dissemination |
| Q44900106 | Prognostic significance of non-curative gastrectomy for incurable gastric carcinoma. |
| Q36739921 | Role of Surgery in the Management for Gastric Cancer with Synchronous Distant Metastases. |
| Q37373079 | Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis |
| Q92862221 | Survival benefit of palliative gastrectomy followed by chemotherapy in stage IV gastric signet ring cell carcinoma patients: A large population-based study |
| Q35858123 | The Value of Palliative Gastrectomy for Gastric Cancer Patients With Intraoperatively Proven Peritoneal Seeding |
| Q38919830 | The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO. |
| Q36671495 | The impact and optimal indication of non-curative gastric resection for stage IV advanced gastric cancer diagnosed during surgery: 10 years of experience at a single institute |
| Q35073207 | The role of non-curative surgery in incurable, asymptomatic advanced gastric cancer |
| Q89354598 | [Resection of advanced esophagogastric adenocarcinoma : Extended indications] |
Search more.